Survivorship and Self Management in Multiple Myeloma

Module

Survivorship and Self Management

Description:
Learn about survivorship and self management strategies for multiple myeloma patients.

Module Objectives:

Understand the concept of survivorship beginning at diagnosis and continuing throughout the myeloma journey
Review essential components of self management for chronic myeloma care
Explore nursing strategies to support patients in proactive health management and care coordination

Instructor:
Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

Tools and Resources:

Conversation Starter for nurses (English and Spanish) – also available in hard copy

Myeloma Treatment Discussion Tool – also available in hard copy

Recommended Routine Health Screenings

Newly Diagnosed Myeloma Patient Resources | The IMF

Long-Term Care Planning | The IMF

Videos:

Living Well with Myeloma: Nutrition and Quality of Life

Living Well with Myeloma: Medicare

Exercising in a Minute or Less

Quality of Life Studies in Myeloma – ASH 2024

Publications:

NLB_2011_CJON_SurvivorshipCareGuidelines

NLB 2016 Cancer Med Lack of health maintenance examinations and risk in myeloma patients

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module

VIEW ALL MODULES

Bispecifics in Multiple Myeloma

Module

Bispecifics in Multiple Myeloma

serious-clinician-studying-chemical-element-in-laboratory

Description:
Learn about bispecifics in multiple myeloma.

Module Objectives:

Review important concepts for bispecifics use in mutiple myeloma
Highlight important nursing considerations for patient education
Learn about the risk assessment in the use of bispecifics

Instructor:
Donna Catamero, ANP-BC, OCN, CCRC

Additional Resources:

A White Paper from the IMF Nurse Leadership Board:
BISPECIFIC ANTIBODY THERAPY: Exploring Efficacy, Safety, and Transition of Care Management

Consensus Guidelines on Immune Therapy Sequencing:
IMWG recommendation on sequencing immunotherapy for treatment of multiple myeloma | Leukemia

Video resource with tips for managing bispecific side effects:
Living Well With Myeloma: Harmonizing Nutrition and Novel Therapies

Print Publications for patients and HCPs:
Understanding Tecvayli | International Myeloma Foundation
Understanding TALVEY™ | International Myeloma Foundation
Understanding Elrexfio | International Myeloma Foundation
Bispecific Therapy Tip Card | Int’l Myeloma Fndtn

Videos for Patients – Myeloma Made Simple Series
Bispecific Antibodies for Myeloma: A Patient’s Guide | Int’l Myeloma Fn
Bispecific Antibody Infection Management | Int’l Myeloma Fn

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module

VIEW ALL MODULES

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

Autologous Stem Cell Transplant, Module

Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

Description:
High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Module Objectives:

Review concepts of who should undergo an ASCT, eligibility and treatment decision making
Provide a brief overview of the ASCT process
Identify special nursing considerations for the community-based provider

Instructor:
Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

Additional Resources:

Nurse Leadership Board Resources – Multiple Myeloma Treatment
Understanding Stem Cell Transplant
Clinical Journal of Oncology Nursing
Supplement Vol. 17 Num. 6 | December 2013
Hematopoietic Stem Cell Transplantation and Multiple Myeloma
Seminars in Oncology Nursing
Vol. 33 issue 3 | August 2017
Multiple Myeloma
Multiple Myeloma: A Textbook for Nurses (3rd edition) | ONS
Chapter 4 | Oncology Nursing Society, Pittsburgh, PA | 2021

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module

VIEW ALL MODULES

Treatments for Multiple Myeloma – Part 2

Myeloma Treatments

Module

Treatment for Multiple Myeloma – Part 2

Description:

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Module Objectives:

Learn about the uses of selinexor, and venetoclax in the context of relapsed myeloma.
Educate healthcare professionals about the potential side effects and considerations of selinexor and venetoclax.

Instructor:

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

Additional Resources:

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module

VIEW ALL MODULES

Treatments for Multiple Myeloma – Part 1

Myeloma Treatments

Module

Treatment for Multiple Myeloma Part 1

Description:

Learn about steroids, IMiDs, and PIs: three classes of drugs used to treat multiple myeloma.

Module Objectives:

Review the uses and typical doses of glucocorticosteroids (steroids), immunomodulatory drugs (IMiDs), and proteasome inhibitors (Pls) when treating multiple myeloma
Familiarize patients and practitioners with common side effects brought about by steroids, iMiDs and PIs
Prepare patients and practitioners for possible concerns which may arise when using steroids, iMiDs and PIs as treatment for myeloma.

Instructor:

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

Additional Resources:

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module

VIEW ALL MODULES

Treatment Selection for Patients with Myeloma

How Treatments are Selected

Module

Treatment Selection for Patients with Myeloma

Description:

Learn the basics of treatment selection in upfront and relapse settings as well as the importance of disease monitoring.

Module Objectives:

Discover how practitioners select treatment for multiple myeloma (MM) in upfront and relapse settings
Review the history, components of various MM treatments, and considerations when going through such treatments
Define remission and day-to-day symptom reduction in myeloma patients

Instructor:

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

Additional Resources:

Multiple Myeloma and Plasma Cell Disorders: Update on Diagnosis, Prognosis, Treatment, and Supportive Care

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module